Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice

被引:144
作者
Firoved, AM
Miller, GF
Moayeri, M
Kakkar, R
Shen, YQ
Wiggins, JF
McNally, EM
Tang, WJ
Leppla, SH
机构
[1] NIAID, Bacterial Toxins & Therapeut Sect, NIH, Bethesda, MD 20892 USA
[2] NIH, Div Vet Resources, Off Res Serv, Bethesda, MD 20892 USA
[3] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[4] Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA
关键词
D O I
10.1016/S0002-9440(10)61218-7
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Bacillus anthracis edema toxin (ET), an adenylyl cyclase, is an important virulence factor that contributes to anthrax disease. The role of ET in anthrax pathogenesis is, however, poorly understood. Previous studies using crude toxin preparations associated ET with subcutaneous edema, and ET-deficient strains of B. anthracis showed a reduction in virulence. We report the first comprehensive study of ET-induced pathology in an animal model. Highly purified ET caused death in BALB/cJ mice at lower doses and more rapidly than previously seen with the other major B. anthracis virulence factor, lethal toxin. Observations of gross pathology showed intestinal intralumenal fluid accumulation followed by focal hemorrhaging of the ileum and adrenal glands. Histopathological analyses of timed tissue harvests revealed lesions in several tissues including adrenal glands, lymphoid organs, bone, bone marrow, gastrointestinal mucosa, heart, and kidneys. Concomitant blood chemistry analyses supported the induction of tissue damage. Several cytokines increased after ET administration, including granulocyte colony-stimulating factor, eotaxin, keratinocyte-derived cytokine, MCP-1/JE, interleukin-6, interleukin-10, and interleukin-1 beta. Physiological measurements also revealed a concurrent hypotension and bradycardia. These studies detail the extensive pathological lesions caused by ET and suggest that it causes death due to multiorgan failure.
引用
收藏
页码:1309 / 1320
页数:12
相关论文
共 57 条
[1]   PATHOLOGY OF INHALATIONAL ANTHRAX IN 42 CASES FROM THE SVERDLOVSK OUTBREAK OF 1979 [J].
ABRAMOVA, FA ;
GRINBERG, LM ;
YAMPOLSKAYA, OV ;
WALKER, DH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (06) :2291-2294
[2]  
Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513
[3]   Anthrax toxin: a tripartite lethal combination [J].
Ascenzi, P ;
Visca, P ;
Ippolito, G ;
Spallarossa, A ;
Bolognesi, M ;
Montecucco, C .
FEBS LETTERS, 2002, 531 (03) :384-388
[4]   Fatal inhalational anthrax in a 94-year-old Connecticut woman [J].
Barakat, LA ;
Quentzel, HL ;
Jernigan, JA ;
Kirschke, DL ;
Griffith, K ;
Spear, SM ;
Kelley, K ;
Barden, D ;
Mayo, D ;
Stephens, DS ;
Popovic, T ;
Marston, C ;
Zaki, SR ;
Guarner, J ;
Shieh, WJ ;
Carver, HW ;
Meyer, RF ;
Swerdlow, DL ;
Mast, EE ;
Hadler, JL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (07) :863-868
[5]  
Basu S, 2002, INT J MOL MED, V10, P3
[6]  
Borish Larry C., 2003, Journal of Allergy and Clinical Immunology, V111, pS460
[7]   Role of toxin functional domains in anthrax pathogenesis [J].
Brossier, F ;
Weber-Levy, M ;
Mock, M ;
Sirard, JC .
INFECTION AND IMMUNITY, 2000, 68 (04) :1781-1786
[8]   Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 KATP channels [J].
Chutkow, WA ;
Pu, JL ;
Wheeler, MT ;
Wada, T ;
Makielski, JC ;
Burant, CF ;
McNally, EM .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (02) :203-208
[9]   Anthrax toxin [J].
Collier, RJ ;
Young, JAT .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2003, 19 :45-70
[10]   Sensitivity of bone to glucocorticoids [J].
Cooper, MS .
CLINICAL SCIENCE, 2004, 107 (02) :111-123